The drug exemestane significantly reduces the risk of breast cancer in high-risk, postmenopausal women is the result of an international, randomized double-blind phase III clinical trial in which University at Buffalo researchers and hundreds of Western New York women played a critical role, revealed at the American Society of Clinical Oncology annual meeting.
Health news and Health articles
Pfizer drug reduces breast cancer in high risk women
http://www.healthnewstrack.com/health-news-2629.html